Since CXCR4 overexpression in tumor tissue has been related to enhanced migration, metastatic potential, and a higher risk of recurrence in HNSCC, we wanted to evaluate its suitability as a receptor for targeted drug delivery. Here, CXCR4 is linked to neoplasm.